Policy Cures

On December 3, Policy Cures released its fifth annual G-FINDER report , a comprehensive survey of funding for research and development for neglected diseases. The report tracks global public, private and philanthropic investments into R&D for 31 diseases, including HIV/AIDS, tuberculosis, malaria and NTDs. In positive news, this year’€™s report shows that total funding has actually increased by $443 million since 2007. The report demonstrates that government funding, which accounts for over two-thirds of all investment, is increasingly going toward basic academic research, rather than product development. Research!America believes it is vital that the entire research pipeline be fully...
A recent unsigned editorial by Bloomberg View restates what we’ve been saying for some time: Americans are not immune from global health problems. The editorial focuses on West Nile virus and dengue, though there are certainly other diseases and conditions that were worthy of inclusion. Worldwide travel means diseases are more transmissible than ever, and climate change gives disease-carrying mosquitoes more hospitable climates, the editorial notes. And a lack of treatments exacerbates the problem. “Patients receive acetaminophen for fever and pain, fluids if they are dehydrated, and get-well wishes,” the editorial states. “No vaccines, no cures and no specific medicines exist to prevent or...